Opto® B Discovery on the Beacon® optofluidic system enables rapid selection of lead candidates by function-forward screening of B cells in under 1 week. This presentation will introduce Berkeley Lights’ newest antibody discovery workflow, the Opto® Memory B Discovery workflow, and share how customers are using the workflow to screen rabbit memory B cells to rapidly discover rabbit monoclonal antibodies (as presented at Antibody Engineering & Therapeutics 2023).
Berkeley Lights Software Suite 2.4 upgrade is loaded with customer-requested features that focus on reduced touchpoints and more intuitive data analysis.
Learn how you can increase scope, scale, and throughput of workflows run on the Beacon and Lightning platforms.